Effect of selected biofilm inhibitors, N-acetylcysteine and DNase, on some biological properties of taurine haloamines (TauCl and TauBr) by Walczewska, Maria et al.
Central European Journal of Immunology 2013; 38(4)434
Experimental immunology DOI: 10.5114/ceji.2013.39758
Correspondence: Maria Walczewska MSc, Jagiellonian University Medical College, +48 12 632 58 65, Czysta 18, 31-121 Krakow, Poland, 
e-mail: maria.walczewska@uj.edu.pl 
Introduction
Taurine chloramine (TauCl) and taurine bromamine 
(TauBr), the major haloamines of the MPO-halide system 
of neutrophils, exert anti-microbial and anti-inflammatory 
properties, as documented in a number of in vitro studies 
[1-11]. Importantly, clinical studies have shown that both 
haloamines are also effective in the local treatment of in-
flammatory diseases, including biofilm-related infections, 
such as otitis externa, chronic rhinosinusitis [13, 14] or 
acne vulgaris [15]. Moreover, TauCl has been proposed as 
a novel therapeutic agent in the treatment and prevention of 
periodontal diseases, chronic infectious diseases related to 
the excessive development of the polymicrobial oral bio-
film [16]. However, mature biofilms, consortia of bacteria 
attached to biological surfaces (e.g. dental plaque) and en-
closed in self-generated matrix, are characterized by a high 
resistance to antibiotics and antiseptics. Therefore, new al-
ternative therapeutic strategies should be tested. One pos-
sibility is to use antiseptics along with anti-biofilm agents 
to increase effectiveness of antimicrobial therapy [17, 18]. 
Only recently we have reported that TauBr is able to 
inhibit in vitro the formation of the Pseudomonas aerugi-
nosa biofilm, but cannot eradicate the mature biofilm and 
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Abstract
antibiotic resistance is a common problem accompanying biofilm-associated chronic infections. new 
therapeutic strategies are based on a combined application of antiseptics with anti-biofilm agents. Tau-
rine haloamines, taurine chloramine (Taucl) and taurine bromamine (TauBr), show antimicrobial and 
anti-inflammatory properties, which have been examined in a variety of local infections, including bio-
film-associated infections. in contrast to beneficial antimicrobial effects of taurine haloamines against 
the planktonic form of bacteria, their efficacy against bacteria hidden in biofilm need to be enhanced. 
one possibility is to use them together with agents capable of destroying components of biofilm matrix. 
in this study we ask a question whether Taucl or TauBr are effective in killing streptococcus mu-
tans and Porphyromonas gingivalis, major oral bacteria responsible for the development of dental 
plaque and pathogenesis of periodontal diseases. Moreover, we have examined TauBr and Taucl 
stability in the presence of n-acetylcysteine (nac) and dnase, agents with known anti-biofilm 
activity. We have found that TauBr was much stronger than Taucl microbicidal agent against 
both tested bacterial strains. however, TauBr was less stable than Taucl. nac readily decom-
posed TauBr but not Taucl. in addition, TauBr inhibited dnase activity, when used in excess.  
This preliminary study confirms previous opinions that taurine haloamines have great potential in kill-
ing oral bacteria. however, further studies are necessary to find anti-biofilm agent(s) which together 
with Taucl/TauBr will give at least an additive therapeutic effect in the treatment of chronic infections, 
to support or replace ineffective antibiotic therapy.
Key words: biofilm, n-acetylcysteine (nac), dnase, taurine bromamine (TauBr), taurine chlora-
mine (Taucl), oral bacteria, periodontal diseases.
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cannot effectively kill bacteria hidden in the biofilm matrix 
[18]. Therefore, it is tempting to test the anti-biofilm effect 
of taurine haloamines in combination with agents which 
can destroy components of biofilm matrix (extracellular 
polysaccharides and/or DNA). 
The aim of this study was to investigate the effect of 
n-acetylcysteine (NAC) and DNase, well-documented an-
ti-biofilm agents, on stability and some biological proper-
ties of taurine haloamines. This laboratory study design 
is the first step in testing therapeutic potential of taurine 
haloamines combined with other anti-biofilm agents for 
a local treatment of biofilm-associated chronic infections, 
such as periodontal diseases. 
Material and methods
Anti-biofilm agents
n-acetylcysteine [2-Acetamido-3-sulfanylpropanoic 
acid] (NAC), bovine pancreatic DNase I (DNase). Both 
reagents purchased from Sigma, Aldrich, Germany.
 Taurine haloamines: taurine chloramine (TauCl) 
and taurine bromamine (TauBr)
TauCl (N-chlorotaurine sodium salt) a kind gift from 
Professor Waldemar Gottardi and Professor Marcus Nagl 
from the Division of Hygiene and Medical Microbiology, 
Innsbruck Medical University, Austria. TauCl as a crystal-
line sodium salt (molecular weight 181.57) was prepared 
as described previously [1]. Each preparation of TauCl was 
monitored by UV absorption spectra (l = 200 to 400 nm) 
to assure the authenticity of TauCl (l = 252 nm) and the 
absence of dichloramine (TauCl2) (l = 300 nm) and unre-
acted HOCl/OCl– (l = 292 nm). The concentration of syn-
thesized TauCl was determined using the molar extinction 
coefficient 429 M-1cm-1 at A252. 
TauBr was prepared in a two-step procedure. First, 
NaOBr was synthesized in reaction between equimolar 
amounts of NaOCl and NaBr (Poch, Poland) in the PBS 
solution. In such conditions virtually all the OCl- present 
reacts with Br– to form OBr– and Cl–. The presence and 
concentration of OBr– was confirmed by UV spectra (l = 
= 200 to 400 nm). In the second step, 20 mM NaOBr was 
added dropwise to an equal volume of 400 mM taurine. UV 
absorption spectrum was checked to exclude the formation 
of taurine dibromamine or chloramines and to estimate the 
concentration of TauBr (molar extinction coefficient – 430 
M-1cm-1 at A
288
). Stock solutions of TauCl and TauBr were 
kept at 4°C for a maximum period of 3 days before use.
Bacterial strains
All tests were performed on Streptococcus mutans 
ATCC 35 668 (S. mutans) and Porphyromonas gingivalis 
ATCC 33 277 (P. gingivalis). 
Animals
The study was performed on CBA male/female mice, 
between 6 and 8 weeks of age, from the breeding unit, 
Department of Immunology UJ CM, Kraków. The mice 
were fed commercial, granulated food and water ad libi-
tum. The study protocol was approved by the Local Ethics 
Committee in Kraków (No. 91/2011).
Peritoneal exudate cells
Peritoneal exudate cells (PECs) isolated from CBA 
mice were induced by intraperitoneal injection of 1.0 ml of 
thioglycolate. The cells were collected 18h later by wash-
ing out the peritoneal cavity with 5 ml of PBS (phosphate 
buffer solution) containing 5U heparin/ml. Then the cells 
were centrifuged and red blood cells were lysed by osmot-
ic shock using distilled water; osmolarity was restored by 
addition of 2 × concentrated PBS.
Measurement of TauCl and TauBr stability
To determine the influence of anti-biofilm agents on 
stability of taurine haloamines, TauBr and TauCl were 
mixed with equimolar concentrations of NAC or DNase 
(3 mM). Reagents were kept in PBS for 60 minutes and 
then the stability of the tested agents was evaluated by 
analysis of their UV spectra, as described above. 
Analysis of DNAse activity
 Digestion of plasmid DNA with DNase I in the 
presence of TauCl or TauBr
One microgram of plasmid DNA pEGFP (Clontech) 
(6500 base pairs) was digested in 20 microliters of the re-
action mixture, containing one microgram of DNase I (2.15 
Kunitz units) and varied concentrations of TauCl or Tau-
Br, in the presence of 40 mM Tris-HCl (pH 8.0), 10 mM 
MgSO
4
 and 1 mM CaCl
2
. Reactions were carried out for 40 
minutes at 37°C and terminated by a thermal inactivation 
of DNase I (10 minutes at 70°C).
Electrophoresis
Digestion mixtures were separated by electrophoresis 
in 0.8% agarose gel, under constant voltage (4V per cen-
timeter of distance between electrodes). Tris-borate buf-
fer was used as a conductive medium (10.8 g/l Tris base, 
5.5 g/l boric acid, 10 mM EDTA pH 8.0) and ethidium 
bromide was used for DNA visualization. Images were 
collected with UV transiluminator (Vilber Lourmat) and 
BioCapt 97.05s software.
Antimicrobial activity of the tested agents
 streptococcus mutans strain was grown in a Muel-
ler-Hinton II Agar (Difco, USA) with 5% sheep blood 
addition at 35oC for 72 hours in aerobic conditions. P. gin-
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givalis was grown in a schaedler agar Base (Difco, USA) 
at 35oC for 7 days in anaerobic conditions. Bacteria were 
centrifuged at 1800 × g, washed twice with 0.9% NaCl 
and diluted in saline to a concentration of 1 × 108 c.f.u./
ml. Before use, bacteria were diluted in a phosphate buffer 
(PBS) (pH 7.4) to achieve a final concentration of 1 × 105 
c.f.u./ml and then incubated with different concentrations 
of TauBr and TauCl. Immediately after the incubation 
(30 min), aliquots were removed and the viable cell count 
was determined by a pour-plate method, as described pre-
viously [2].
 Measurement of reactive oxygen 
species generation: luminol-dependent 
chemiluminescence
The effect of TauCl, TauBr and NAC on the generation 
of reactive oxygen species (ROS) by neutrophils was eval-
uated in vitro using luminol-dependent chemiluminescence 
(LCL). LCL was counted at 37°C in temperature-stabi-
lized luminometer Lucy 1 (Anthos, Austria). Briefly, 18-
hour PECs induced by thioglycolate (5 × 105/well), were 
Table 1. Minimal inhibitory concentration of TauCl and 
TauBr [19] 
Minimal inhibitory 
concentration MIC]
S. mutans P. gingivalis
TauCl 3 mM 188 mM
TauBr 24 mM 48 mM
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Fig. 1. Generation of ROS by PECs stimulated with op-
sonized zymosan (OZ) or killed bacteria (s. mutans or 
P. gingivalis). Ctrl – non-stimulated cells. LCL was per-
formed and measured as described in methods. The figure 
shows one representative experiment
preincubated with tested agents in Hank’s balanced salt 
solution (10 min at 37°C in an atmosphere of 5% CO2) 
on a 96-well flat-bottom black plate (Nunc, Denmark). 
Then, the cells were mixed with luminol (0.8 mg/ml) at 
the 1 : 1 volume ratio (both Sigma-Aldrich, Germany) and 
incubated at 37°C for another 30 min. After incubation, 
the cells with TauCl, TauBr and/or NAC were immedi-
ately stimulated with opsonized zymosan 200 µg/ml (Sig-
ma-Aldrich, Germany) or killed bacteria (S. mutans or 
P. gingivalis) at a ratio of 100 : 1 (bacteria to the cells). 
Photon emission over 75 min with 3-min intervals was 
measured. Results are expressed as relative unit light 
(RUL) where photons were counted every 5 seconds. 
Results 
 Antimicrobial capacity of TauCl, TauBr against 
S. mutans, P. gingivalis
To confirm that taurine haloamines are good candi-
dates for the treatment of periodontal diseases, their anti-
microbial activity against the planktonic form of selected 
dental plaque bacteria was tested in vitro. 
TauCl presents much weaker antimicrobial potential 
against tested bacterial strains than TauBr, as shown in 
Table 1. Minimal inhibitory concentration (MIC) of TauCl 
Fig. 2. Effect of TauCl and TauBr on ROS production by 
PECs stimulated with opsonized zymosan. PECs (5 × 105/
well), were preincubated with the tested agents, TauCl, 
TauBr or TauCl+TauBr for 10 minutes. Then, LCL was 
performed and measured as described in methods. Ctrl – 
non-stimulated cells. OZ – stimulated cells, positive con-
trol LCL = 100%. The figure shows one representative 
experiment
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for P. gingivalis was ~3.5 times higher than that of Tau-
Br. Much bigger differences between TauBr and TauCl 
antimicrobial activities against s. mutans were observed. 
MIC of TauBr was 188 µM while TauCl effectively killed 
s. mutans at concentrations above 3 mM. 
 Generation of ROS by PECs in the presence  
of TauCl, TauBr and NAC
To determine whether tested agents affect ROS gen-
eration by inflammatory cells, peritoneal exudate cells 
were stimulated either with opsonized zymosan (OZ) or 
bacteria (s. mutans, P. gingivalis) in the presence of the 
agents. Both, opsonized zymosan and s. mutans, induced 
massive generation of ROS, as measured by LCL (Fig. 1). 
In contrast, P. gingivalis, an anaerobic bacterial strain, was 
a much weaker inducer of ROS generation (Fig. 1).
Both haloamines show a significant, dose-dependent 
reduction of LCL induced with all stimuli (OZ – Fig. 2; 
s. mutans, P. gingivalis – Fig. 4, Table 2), with the strong 
additive effect when added together (inhibition > 90%). At 
the used concentrations NAC was a much weaker antioxi-
dant than both haloamines. Importantly, there was no addi-
tive antioxidant effect when NAC was incubated together 
with TauCl (Fig. 3 and Fig. 5B). DNase did not affect ROS 
generation (data not shown).
 Effect of NAC and DNase on the stability  
of TauCl and TauBr 
To answer the question whether NAC and DNase af-
fect stability of TauCl and TauBr and in consequence af-
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Fig. 3. Effect of TauCl and NAC on ROS production by 
PECs stimulated with opsonized zymosan. PECs (5 × 105/
well) were preincubated with tested agents TauCl, NAC 
and TauCl + NAC for 10 minutes. Then, LCL was per-
formed and measured as described in methods. Ctrl – con-
trol, non-stimulated cells. OZ – stimulated cells. The figure 
shows one representative experiment
Fig. 4. Effect of TauCl and TauBr on ROS production by PECs stimulated with P. gingivalis (A) or s. mutans (B). PECs 
(5 × 105/well) were preincubated with TauCl and/or TauBr for 10 minutes. Then, LCL was performed and measured as 
described in methods. Ctrl – control, non-stimulated cells. The figure shows one representative experiment
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fect their expected biological properties, the UV spectra 
were analyzed. As shown in Fig. 6, at neutral pH the UV 
spectrum of TauBr disappeared after NAC addition, while 
there was no influence of NAC on the UV spectrum of 
TauCl when both reagents were used at the equimolar con-
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Table 2. The inhibitory effect of TauCl, TauBr and NAC on the ROS production by PECs 
% inhibition of ROS production*
TauCl
100
TauCl
300
TauBr
100
TauBr
300
TauCl
100
+
TauBr
100
TauCl
300
+
TauBr
300
TauCl
300
+
NAC
30
NAC
30
Induction of ROS 
generation with opsonized 
zymosan
8 27 47 83 48 90 35 31
Induction of ROS 
production with s. mutans
- 72 - 64 - 98 74 35
* % inhibition has been calculated from the results shown in Figs. 1-5
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Fig. 5. Effect of TauCl and NAC on ROS production by PEC stimulated with P. gingivalis (A) or s. mutans (B). PECs 
(5 ×105/well) were preincubated with the tested agents TauCl and/or NAC for 10 minutes. Then, LCL was performed and 
measured as described in methods. Ctrl – control, non- stimulated cells. The figure shows one representative experiment
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ctrl         s. mutans              TauCl
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NAC
300 mM + s. mutans               TauCl300 mM  + NAC300 mM + s. mutans
BA
centrations. DNase had no effect on UV spectra of TauCl 
and TauBr (Fig. 7). These results clearly indicate that NAC 
but not DNase strongly affects stability of TauBr. 
 Effect of TauCl and TauBr on the activity  
of DNase  
To examine the effect of TauCl and TauBr on DNase ac-
tivity, plasmid DNA was digested with DNAse alone or with 
DNase in the presence of various concentrations of TauCl or 
TauBr. Digestion mixtures were separated by electrophoresis 
in 0.8% agarose gel as described in methods. DNAse used at 
a concentration of 50 mg/ml digested plasmid DNA (lanes 
2-9). Either TauCl or TauBr alone did not affect the struc-
ture of plasmid DNA (data not shown). TauCl (lanes 8, 9) 
did not affect the activity of DNAse. Interestingly, TauBr in 
contrast to TauCl  inhibited the activity of DNAse. The in-
activation of DNAse was observed when TauBr was added 
in excess to DNAse (TauBr > 500 mM).
Discussion 
Oral biofilm (dental plaque) is a polymicrobial bio-
film growing on hard and soft dental surfaces and is 
considered the main etiological factor for gingivitis and 
periodontitis [17]. Among a variety of oral bacteria, 
streptococcus mutans and Porphyromonas gingivalis 
play a crucial role in the formation of dental plaque and 
in the pathogenesis of periodontal diseases, respective-
ly [17, 18, 20-22]. Modern concepts for the prevention 
and therapy of biofilm-associated infections are based on 
eradication of the biofilm by using antibiotics combined 
Central European Journal of Immunology 2013; 38(4) 439
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Fig. 6. Effect of NAC on the stability of TauCl (A) and TauBr (B) performed at pH 7,4. TauCl, TauBr and NAC solutions 
were mixed in equimolar concentrations (3 mM). The UV spectra were measured as described in methods
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Fig. 7. Effect of DNase on the stability of TauCl (A) and TauBr (B) at pH 7.4. TauCl, TauBr and DNase solutions were 
mixed in equimolar concentrations (3 mM). The UV spectra were measured as described in methods
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with adjuvant substances, capable of destroying biofilm 
matrix. Nevertheless, none of the currently available ther-
apies are effective due to extreme resistance of biofilm 
bacteria to antimicrobial agents. It has been documented 
that bacteria within a biofilm can be even 1000 times 
more resistant to antibiotics than their planktonic coun-
terparts [18]. To overcome this problem a variety of sub-
stances with a capacity to reduce biofilm growth has been 
tested, including NAC and DNase.
n-acetylcysteine is a thiol (sulfhydryl groups) – con-
taining antioxidant with antibacterial properties and is 
a precursor in the formation of the antioxidant glutathi-
one in the body. NAC, due to its mucus-dissolving prop-
erties, is used in medical treatment of chronic bronchitis. 
Recently, it has been found that NAC can increase thera-
peutic efficacy of antibiotics by degrading the extracellular 
polysaccharide matrix of biofilms [23-26]. However, the 
efficacy of NAC in reduction of dental plaque (oral bio-
film bacteria) has not been tested yet. DNase, the second 
antibiofilm agent we have used in this study, also has the 
capacity to destroy components of the biofilm matrix, such 
as extracellular DNA. For example, the capacity of DNase 
to disrupt P. aeruginosa biofilm has been shown by Mo-
hammed et al. [27, 28]. 
The main task of this study was to determine whether 
NAC or DNase can be used in combination with taurine 
Central European Journal of Immunology 2013; 38(4)440
Maria Walczewska et al.
Plasmid DNA + + + + + + + + +
DNase – + + + + + + + +
TauBr
25 mM  – – + – – – – – –
TauBr
50 mM  – – – + – – – – –
TauBr
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TauBr
500 mM  – – – – – + – – –
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Fig. 8. Gel electrophoresis of plasmid DNA in the presence of DNAse at concentration of 50 mg/ml (lanes 2-9) and TauCl 
at concentrations 25, 1500 mM (lanes 8, 9) or TauBr at concentrations 25, 50, 150, 500, 1500 mM (lanes 3-7). Time of 
digestion of plasmid DNA was 40 minutes. Line 1 plasmid DNA without digestion
haloamines in the local treatment of biofilm-associated in-
fections, especially in the treatment of periodontal diseas-
es. We have chosen taurine haloamines (TauCl and TauBr) 
as previously our group and the others have shown their 
anti-inflammatory and antibacterial properties and promis-
ing potential in the local treatment of chronic (biofilm-as-
sociated) infectious diseases [13-16].
This study shows that at a neutral pH both monoha-
loamines, TauCl and TauBr, can effectively kill the plank-
tonic form of dental plaque bacteria, namely, s. mutans 
and P. gingivalis. However, TauCl antimicrobial activi-
ty was observed at very high concentrations. It indicates 
that TauCl is a relatively weak antiseptic agent. On the 
other hand, in acidic milieu (pH 4-6), which is typical 
of an inflammatory environment, the ability of TauCl to 
kill pathogens increases significantly due to formation of 
a more potent TauCl2 (taurine dichloramine). TauCl2 has 
stronger bactericidal properties than TauCl, especially 
against Gram-negative bacteria probably due to a better 
penetration into bacteria. In addition, transfer of the active 
chlorine (transchlorination) from TauCl to amino groups 
of other molecules enhances its activity, mainly because of 
the formation of monochloramine (NH
2
Cl) [29, 30]. 
TauBr, in contrast to TauCl, shows the microbicid-
al activity at very low concentrations < 10 µM, even as 
taurine monobromamine. Therefore, these results, togeth-
er with our previous study [2, 20], suggest that TauBr is 
a more promising candidate than TauCl for killing bacte-
ria hidden in the biofilm matrix, but, as TauCl is a more 
stable molecule than TauBr, we were tempted to examine 
the effect of anti-biofilm agents on activity of both taurine 
haloamines.
Previously, we have shown that TauBr but not TauCl 
is decomposed by H
2
O
2
 [7]. In this study, the low stabili-
ty (high reactivity) of TauBr has been confirmed. Analy-
sis of UV spectra clearly indicates that NAC completely 
decomposed TauBr without any effect on the stability of 
TauCl. The effect of NAC on TauBr may be explained by 
its antioxidant/scavenging properties. NAC is a powerful 
scavenger of some oxidants, such as hypochlorous acid 
and hydrogen peroxide [31]. In contrast to NAC, DNase, 
the second tested antibiofilm agent, did not affect the sta-
bility of either TauCl or TauBr. On the other hand, TauBr 
inhibited DNase enzymatic activity, when used at a con-
centration similar to that of DNase or in excess. 
To prove whether NAC and DNAse are able to en-
hance anti-inflammatory properties of taurine haloamines, 
we also examined their ability to reduce ROS generation 
by activated inflammatory cells. Our previous [6, 7] and 
present results clearly indicate that both taurine haloamines 
can reduce generation of ROS by neutrophils (major cells 
of PECs) stimulated with opsonized zymosan (activation 
through FcR). The similar antioxidant effect of TauCl and 
TauBr was observed after stimulation of PECs with P. gin-
givalis and s. mutans (activation through TLRs) (Table 2). 
Therefore, we suggest that TauCl and TauBr may in vivo 
ameliorate inflammatory response induced by oral biofilm 
bacteria. Importantly, DNase did not show any effect on 
ROS production, while NAC confirmed its own antiox-
idant potential. However, the additive effect of NAC on 
antioxidant properties of TauCl in vitro was negligible, in 
our experimental set-up.
In conclusion, this preliminary study confirms previ-
ous suggestions that taurine haloamines, due to their an-
ti-microbial and anti-inflammatory properties, are good 
candidates for a local treatment of periodontal diseases. 
It has become clear that they should be used in a com-
bination with anti-biofilm agents to be more effective in 
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killing of biofilm-associated bacteria (e.g. P. gingivalis in 
the subgingival biofilm). However, expected positive ther-
apeutic efficacy of such combination treatment requires 
good stability of both components and synergistic or at 
least additive antimicrobial effect. Therefore, NAC can be 
combined with TauCl but not with TauBr. On the other 
hand, the outstanding anti-microbial properties of TauBr 
indicate that TauBr with another adjuvant agent should be 
used in prevention and eradication of bacterial biofilms. 
Therefore, further studies should examine influence of 
matrix-degrading compounds on anti-inflammatory and 
anti-bacterial properties of taurine haloamines, especially 
on TauBr, the more promising local antiseptic.
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